Norfloxacin-d5 structure
|
Common Name | Norfloxacin-d5 | ||
---|---|---|---|---|
CAS Number | 1015856-57-1 | Molecular Weight | 324.36200 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C16H13D5FN3O3 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of Norfloxacin-d5Norfloxacin-d5 is a deuterium labeled Norfloxacin. Norfloxacin is a fluoroquinolone antibiotic that inhibits the growth of Gram-positive and Gram-negative bacteria (MICs = 4 μg/mL and 1 μg/mL for S. aureus and P. aeruginosa, respectively). Norfloxacin also inhibits the growth S. pseudintermedius, S. aureus, E. coli, Pasturella, and S. canis isolates from dogs (mean MIC50s = 0.25 μg/mL, 1 μg/mL, 0.03 μg/mL, 1 μg/mL, and 1 μg/mL, respectively). |
Name | 1-(2H5)Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid |
---|---|
Synonym | More Synonyms |
Description | Norfloxacin-d5 is a deuterium labeled Norfloxacin. Norfloxacin is a fluoroquinolone antibiotic that inhibits the growth of Gram-positive and Gram-negative bacteria (MICs = 4 μg/mL and 1 μg/mL for S. aureus and P. aeruginosa, respectively). Norfloxacin also inhibits the growth S. pseudintermedius, S. aureus, E. coli, Pasturella, and S. canis isolates from dogs (mean MIC50s = 0.25 μg/mL, 1 μg/mL, 0.03 μg/mL, 1 μg/mL, and 1 μg/mL, respectively). |
---|---|
Related Catalog |
Molecular Formula | C16H13D5FN3O3 |
---|---|
Molecular Weight | 324.36200 |
Exact Mass | 324.16500 |
PSA | 74.57000 |
LogP | 1.66210 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
Development and validation of an ultra high performance liquid chromatography tandem mass spectrometry method for simultaneous determination of sulfonamides, quinolones and benzimidazoles in bovine milk.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 962 , 20-9, (2014) A simple, sensitive and reliable analytical method was developed for the simultaneous determination of 38 veterinary drugs (18 sulfonamides, 11 quinolones and 9 benzimidazoles) and 8 metabolites of be... |
MFCD08460517 |